AI-Powered navigation aims to boost colon cancer screening in 45-49 year olds
NCT ID NCT07230795
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses artificial intelligence to find people aged 45-49 who are at higher risk for colorectal cancer but have never been screened. Participants are randomly assigned to receive either standard care or extra help from a patient navigator who guides them through getting a stool test or colonoscopy. The goal is to see if this personalized outreach increases screening rates and catches cancer earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
patient navigation
What this could lead to
If successful, this approach could increase colorectal cancer screening rates and catch more cancers early in younger adults.
What could go wrong
This is a behavioral intervention study, not a drug trial. The AI risk model may not be perfectly accurate, and screening uptake may not increase as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19003, United States